Clinical Trials Logo

Clinical Trial Summary

The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.


Clinical Trial Description

Up to 20 subjects will be enrolled at 1 study center. Subjects will be enrolled into one of 2 groups. Group A will receive split face treatments with the Potenza and Morpheus. Group B will receive treatments on the face, abdomen, and/or back with Potenza and/or Morpheus. Subjects will attend a screening/pretreatment visit which may be performed on the same day as the treatment visit. Subjects will receive up to 3 treatments with Potenza (and Morpheus). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06023303
Study type Interventional
Source Cynosure, Inc.
Contact
Status Completed
Phase N/A
Start date June 21, 2023
Completion date August 10, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06111482 - Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments. N/A
Recruiting NCT02296450 - Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Recruiting NCT02471352 - Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Completed NCT06059417 - Foam Tape Allergy a Sticky Situation N/A
Completed NCT02122432 - Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions N/A